Clinicians Are Calling a Game-Changer under-eye treatment
What Is Lapiena PN Eyes and Why Is It Redefining Periorbital Rejuvenation? A comprehensive guide to polynucleotide under-eye treatment the science, the ingredients, the results, and what to expect.
The skin around the eyes is unlike any other area of the face. It is the thinnest, the most delicate, and because we blink approximately 10,000 times a day the most mechanically stressed. It is also, for most people, where the signs of ageing appear first and where conventional treatments consistently fall short.
Dark circles, hollow tear troughs, fine lines, puffiness, and a general loss of firmness in the periorbital area are some of the most searched aesthetic concerns in the UK and globally. Yet for years, the available options were limited: topical creams that could not penetrate deeply enough, or filler treatments that added volume but did not address the underlying skin quality.
Lapiena PN Eyes changes that equation. It is a specialist under-eye polynucleotide booster a professionally administered injectable treatment formulated specifically for the periorbital zone, combining medical-grade Polynucleotide (PN) with a precisely selected brightening complex and peptide blend to address every major cause of under-eye ageing simultaneously.
This guide explains everything you need to know: what polynucleotides are, why the under-eye area is so uniquely challenging to treat, how Lapiena PN Eyes works at a cellular level, and what real results look like.
Why the Under-Eye Area Is So Difficult to Treat
The periorbital skin the thin layer surrounding and beneath the eyes presents unique challenges that make it one of the most technically demanding areas in aesthetic medicine:
- Skin thickness of less than 0.5mm in the under-eye area compared to 2mm elsewhere on the face, making it extremely susceptible to mechanical damage, dehydration, and visible deterioration
- A high density of blood vessels close to the surface, which contribute to the bluish or brownish discolouration we recognise as dark circles
- Constant movement from blinking, squinting, and facial expression accelerates the breakdown of the extracellular matrix (ECM) the structural scaffold that keeps skin firm and plump
- Reduced sebaceous gland activity means the under-eye area produces very little of its own natural oil, leaving it vulnerable to chronic dryness and barrier disruption
- Lymphatic drainage in this area is less efficient than elsewhere on the face, contributing to fluid retention and puffiness that makes the skin look tired and aged
Clinical context
Deterioration of the extracellular matrix (ECM) in the periorbital zone is considered the primary driver of periorbital ageing. As collagen, elastin, and hyaluronic acid within the ECM decline, the skin loses the structural support that keeps it smooth, firm, and luminous. Conventional treatments that address only volume loss miss this fundamental biological process — which is why polynucleotide-based treatments represent such a significant advance.
Conventional approaches hyaluronic acid fillers, laser treatments, topical retinoids each address one or two of these challenges. None addresses all of them. And in an area as unforgiving as the under-eye zone, a partial solution frequently produces a partial result.
Lapiena PN Eyes was designed with this complexity in mind. Its formulation targets ECM deterioration, weakened skin barrier, pigmentation, and collagen decline simultaneously, in a single treatment.
What Are Polynucleotides and Why Are They Revolutionary for Under-Eye Treatment?
Polynucleotides (PN) are long-chain DNA fragments derived from natural biological sources in the case of Lapiena PN Eyes, from salmon germ cells, which share over 95% genetic similarity with human DNA. This high degree of biocompatibility is one of the key reasons medical-grade PN are so well tolerated by the body.
Unlike hyaluronic acid fillers, which primarily add volume, or collagen stimulators, which trigger a wound-healing response, polynucleotides work by improving the fundamental biological environment of the skin itself. They are classified as biorevitalisers and biostimulators meaning they restore the conditions the skin needs to regenerate itself, rather than simply replacing what has been lost.
What polynucleotides do at a cellular level:
- Stimulate fibroblast proliferation - the cells responsible for producing collagen, elastin, and hyaluronic acid within the dermis
- Boost dermal density and thickness - rebuilding the structural matrix that thins with age and environmental damage
- Enhance the skin's regenerative environment - creating optimal conditions for cellular repair and tissue renewal
- Reduce micro-inflammation - calming the low-grade chronic inflammation that accelerates ECM breakdown in the periorbital zone
- Support wound healing and tissue repair - Lapiena's PN is approved by the MFDS (Ministry of Food and Drug Safety, South Korea) for wound healing and tissue repair following skin transplantation
What makes Lapiena's PN premium grade
Lapiena PN Eyes contains PN at a concentration of 0.5%, a clinically meaningful level that places it in the medical-grade category. At this concentration, PN actively stimulates fibroblast growth and measurably improves dermal density and thickness. Lower concentrations found in some over-the-counter products cannot achieve the same biological effect.
For the under-eye area specifically, polynucleotides offer something no other class of ingredient can match: the ability to improve the quality and biological health of the skin itself, from within, producing results that deepen over multiple sessions as the skin's own regenerative capacity is restored.
Lapiena PN Eyes: Full Ingredient Profile and Mechanism
What distinguishes Lapiena PN Eyes from single-ingredient PN treatments is its multi-active formulation. Rather than relying on polynucleotides alone, it combines them with a precision brightening complex and an eye-specific peptide blend addressing every major pathway of periorbital ageing in a single treatment.
| Ingredient | Category | Under-eye specific action |
|---|---|---|
| Sodium DNA (PN 0.5%) | Premium Polynucleotide | Stimulates fibroblast growth, boosts collagen & elastin, repairs damaged skin environment, reduces micro-inflammation. |
| Niacinamide (NA) | Vitamin B3 / Brightener | Inhibits melanin transfer, evens skin tone, strengthens the delicate under-eye barrier. |
| Tranexamic Acid (TXA) | Brightening / Depigmenting | Regulates melanin production pathway, reduces pigmentation and vascular dark circles. |
| Nicotinoyl Dipeptide-23 (ND) | Eye-specific peptide | Improves microcirculation, brightens tone, supports energy metabolism in thin periorbital skin. |
| Palmitoyl Pentapeptide-4 (PP) | Signal peptide | Stimulates collagen synthesis signalling, improves elasticity and fine lines, strengthens thin skin. |
| Trehalose | Protective sugar / Humectant | Retains moisture, protects cells from osmotic stress, reduces dryness-related fine lines. |
The Three-Step Regenerative Mechanism
Lapiena PN Eyes operates through three sequential, synergistic pathways each addressing a distinct aspect of under-eye deterioration:
| Step 1 Skin Regeneration |
Step 2 Brightening & Dark Circle Care |
Step 3 Wrinkle & Elasticity Improvement |
|---|---|---|
Sodium DNA (PN)
|
Niacinamide + Tranexamic Acid
|
Peptide Complex (ND + PP)
|
The power of this three-step structure lies in the sequencing: Sodium DNA first prepares the skin environment for optimal regeneration, the brightening agents then correct the pigmentation and vascular changes that cause dark circles, and the peptide complex finalises the treatment by rebuilding the structural collagen matrix that firmness and smooth texture depend on.
No single ingredient class achieves all three. The combination is what makes Lapiena PN Eyes a genuinely comprehensive periorbital treatment rather than a targeted intervention.
Benefits of Lapiena PN Eyes: What to Expect
Based on the product's formulation and the clinical profile of its active ingredients, Lapiena PN Eyes delivers the following clinically relevant outcomes:
Improvement of fine lines and crow's feet
Palmitoyl Pentapeptide-4 activates collagen synthesis signalling in fibroblasts, improving the skin's structural matrix and visibly reducing the depth and appearance of fine lines around and beneath the eye over successive treatments.
Reduction of dark circles
The dual-action brightening complex Niacinamide and Tranexamic Acid addresses both types of dark circle from different angles. Niacinamide inhibits the transfer of melanin to the skin surface (targeting pigmentation-type dark circles), while Tranexamic Acid regulates the melanin production pathway upstream, reducing pigmentation at its source.
Together they address both vascular and pigmentation causes of under-eye discolouration the most common and most difficult to treat combination.
Under-eye skin regeneration and improved texture
Premium-grade Sodium DNA at 0.5% concentration directly improves the skin's regenerative environment, stimulating fibroblast activity and supporting the recovery of damaged periorbital tissue. Over a course of treatments, this translates to measurably improved skin quality firmer, denser, and more resilient under-eye skin.
Deep hydration and barrier restoration
Trehalose a naturally occurring protective sugar acts as a powerful humectant and cytoprotectant, retaining moisture in the delicate under-eye tissue, protecting skin cells from osmotic and environmental stress, and reducing the dryness-related fine lines that compound the appearance of fatigue and ageing.
Enhanced skin vitality and microcirculation
Nicotinoyl Dipeptide-23 is an eye-specific peptide that improves microcirculation and energy metabolism in the thin periorbital skin directly addressing one of the underlying vascular causes of dark circles and restoring the natural brightness and vitality of the under-eye zone.
Treatment note
Results from Lapiena PN Eyes develop progressively over a course of treatments as the polynucleotide component stimulates cumulative fibroblast activity and collagen remodelling. Most patients begin to notice improvements in skin quality and hydration within 2–3 weeks of the first session, with more significant structural improvements in firmness and dark circle reduction becoming visible after 3–4 sessions spaced 2–4 weeks apart. Your practitioner will advise on the protocol most appropriate for your skin.
Who Is Lapiena PN Eyes Suitable For?
Lapiena PN Eyes has been specifically designed for patients experiencing any combination of the following periorbital concerns:
Persistent dark circles that have not responded to topical treatments
- Fine lines and crepey texture beneath and around the eyes
- Loss of skin firmness and elasticity in the periorbital zone
- Dehydrated, dull, or thinning under-eye skin
- Post-procedure under-eye skin that requires regenerative support
- Patients seeking a non-surgical alternative to tear trough filler for skin quality improvement rather than volume replacement
Complement to hyaluronic acid tear trough treatments
It is also an excellent complement to hyaluronic acid tear trough treatments: where filler addresses structural volume loss, Lapiena PN Eyes addresses the quality and health of the overlying skin producing a result that is both more natural and more comprehensive than either treatment alone.
| Concern addressed | Topical eye cream | HA tear trough filler | Lapiena PN Eyes |
|---|---|---|---|
| Dark circle reduction | Limited | None | ✓ Dual-action |
| Fine line improvement | Minimal | Indirect | ✓ Peptide-targeted |
| Skin regeneration (ECM) | None | None | ✓ PN-driven |
| Collagen stimulation | Surface only | None | ✓ Fibroblast signalling |
| Hydration / barrier | Yes (topical) | None | ✓ Deep & sustained |
| Skin quality improvement | Partial | None | ✓ Comprehensive |
| Volume restoration | None | ✓ Primary function | Complementary use |
Treatments For Under-Eye
The under-eye area has long been one of the most challenging zones in aesthetic medicine complex in biology, unforgiving in appearance, and resistant to treatments designed for less specialised applications.
Lapiena PN Eyes represents a genuine advance: a treatment formulated from the ground up for the specific biological challenges of the periorbital zone, combining medical-grade polynucleotide technology with precisely targeted brightening and peptide actives to deliver comprehensive regeneration where it is most needed.
For practitioners looking to offer patients a non-surgical under-eye treatment that addresses skin quality rather than simply adding volume, and for patients seeking a scientifically grounded solution to dark circles, fine lines, and loss of vitality around the eyes Lapiena PN Eyes is a category-defining option.
0 comments